Parklaan 46 B-2300 Turnhout, Belgium   +32 14 720275   info@horsten.be
CHINA
BRUSSELS

NEWS

Horsten sells its shares in Vemedia Pharma
18.1.2013

IK INVESTMENT ACQUIRES A MAJORITY OF VEMEDIA PHARMA

Funds advised by IK Investment Parners (IK) have acquired over 99% of the shares of Vemedia Pharma NV (Vemedia), a leading European OTC producer and distributor of pharmaceuticals (and owner of among others the Valdispert brand). From the aforementioned 99% of the Vemedia shares, 78.4% was acquired by means of an agreement entered into on 11 October 2012 with the reference shareholders of Vemedia and the balance via a voluntary public take-over bid on all other outstanding shares and warrants of Vemedia. IK paid a price of EUR 2.80 per Vemedia share which values Vemedia at EUR 140 million.

Horsten International has been a minority shareholder in Vemedia Pharma since 2007 (after the acquisition of Metapharma NV by Vemedia Pharma). Due to the aforementioned acquisition of Vemedia by IK, also Horsten International has decided to sell its shares in Vemedia Pharma.

< back to overview